In principle, the COVID-19 outbreak could provide a compelling new justification for expediting the processing of certain Freedom of Information Act requests related to the pandemic. But it is more likely to slow down the handling of most requests as agency employees work remotely and other concerns are understandably prioritized.
The impact of COVID-19 was surveyed by the Congressional Research Service in Freedom of Information Act (FOIA) Processing Changes Due to COVID-19: In Brief, March 27, 2020.
Other noteworthy new and updated reports from CRS include:
U.S. Role in the World: Background and Issues for Congress, updated March 27, 2020
The Employment-Based Immigration Backlog, March 26, 2020
Demographic and Social Characteristics of Persons in Poverty: 2018, March 26, 2020
Occupational Safety and Health Administration (OSHA): Emergency Temporary Standards (ETS) and COVID-19, March 26, 2020
Arms Control and Nonproliferation: A Catalog of Treaties and Agreements, updated March 26, 2020
Congressional Use of Advisory Commissions Following Crises, CRS In Focus, March 25, 2020
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
We sit on the verge of another Presidential election – an opportunity for meaningful, science-based policy innovations that can appeal to lawmakers on both sides of the aisle.
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.